Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Gastrointestinal Surgery
Published in: Journal of Gastrointestinal Surgery 6/2018

01-06-2018 | Original Article

Predictors of Short-Term Readmission After Pancreaticoduodenectomy

Authors: Rajesh Ramanathan, Travis Mason, Luke G. Wolfe, Brian J. Kaplan

Published in: Journal of Gastrointestinal Surgery | Issue 6/2018

Login to get access

Abstract

Background

Readmissions are a common complication after pancreaticoduodenectomy and are increasingly being used as a performance metric affecting quality assessment, public reporting, and reimbursement. This study aims to identify general and pancreatectomy-specific factors contributing to 30-day readmission after pancreaticoduodenectomy, and determine the additive value of incorporating pancreatectomy-specific factors into a large national dataset.

Methods

Prospective American College of Surgeons-National Surgical Quality Improvement Project (ACS-NSQIP) data were retrospectively analyzed for patients who underwent pancreaticoduodenectomy (PD) between 2011 and 2015. Additionally, a subset of patients with pancreatectomy-targeted data between 2014 and 2015 were analyzed.

Results

Outcomes of 18,440 pancreaticoduodenectomies were analyzed, and found to have an 18.7% overall readmission rate. Multivariable modeling with pancreatectomy-specific variables increased the predictive value of the model (area under receiver operator characteristic 0.66 to 0.73). Statistically significant independent contributors to readmission included renal insufficiency, sepsis, septic shock, organ space infection, dehiscence, venous thromboembolism, pancreatic fistula, delayed gastric emptying, need for percutaneous drainage, and reoperation.

Conclusions

Large registry analyses of pancreatectomy outcomes are markedly improved by the incorporation of granular procedure-specific data. These data emphasize the need for prevention and careful management of perioperative infectious complications, fluid management, thromboprophylaxis, and pancreatic fistulae.
Appendix
Available only for authorised users
Literature
1.
2.
Yeo CJ, Cameron JL, Sohn TA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg. 1997;226(3):248–57; discussion 257-60.CrossRefPubMedPubMedCentral
3.
Newhook TE, LaPar DJ, Lindberg JM, Bauer TW, Adams RB, Zaydfudim VM. Morbidity and mortality of pancreaticoduodenectomy for benign and premalignant pancreatic neoplasms. J Gastrointest Surg. 2015;19(6):1072–1077.CrossRefPubMed
4.
Fong Y, Sun RL, Jarnagin W, Blumgart LH. An analysis of 412 cases of hepatocellular carcinoma at a western center. Ann Surg. 1999;229(6):790–9; discussion 799-800.CrossRefPubMedPubMedCentral
5.
Ahmad SA, Edwards MJ, Sutton JM, et al. Factors influencing readmission after pancreaticoduodenectomy: a multi-institutional study of 1302 patients. Ann Surg. 2012;256(3):529–537.CrossRefPubMed
6.
Gawlas I, Sethi M, Winner M, et al. Readmission after pancreatic resection is not an appropriate measure of quality. Ann Surg Oncol. 2013;20(6):1781–1787.CrossRefPubMed
7.
8.
Medicaid Program. Payment adjustment for provider-preventable conditions including health care-acquired conditions.. 2011;Vol. 76, No. 108.
9.
10.
11.
Agency for Healthcare Research and Quality. AHRQ quality indicators: Guide to patient safety indicators. 2003(March).
12.
Centers for Medicare and Medicaid Services (CMS), HHS. Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2008 rates. Fed Regist. 2007;72(162):47129–48175.
13.
Centers for Medicare and Medicaid Services (CMS), HHS. Hospital-acquired condition reduction program fiscal year 2017 fact sheet. 2017.
14.
Ramanathan R, Leavell P, Stockslager G, Mays C, Harvey D, Duane TM. Validity of agency for healthcare research and quality patient safety indicators at an academic medical center. Am Surg. 2013;79(6):578–582.PubMed
15.
Duane TM, Ramanathan R, Leavell P, Mays C, Ober J. CAUTIs and CLABSIs: do physicians REALLY know what they are? Surg Infect (Larchmt). 2016;17(1):13–16.CrossRefPubMed
16.
Duane TM, Ramanathan R, Leavell P, Mays C, Harvey D. Concurrent surgical patient safety indicator evaluation results in more accurate reporting and reimbursement. Am Surg. 2014;80(8):776–777.PubMed
17.
Ramanathan R, Leavell P, Stockslager G, Mays C, Harvey D, Duane TM. Validity of ICD-9-CM screening for sepsis in surgical mortalities. Surgical infections. 2014(in press).
18.
Rosen AK, Itani KM, Cevasco M, et al. Validating the patient safety indicators in the veterans health administration: do they accurately identify true safety events? Med Care. 2012;50(1):74–85.CrossRefPubMed
19.
Kaafarani HM, Borzecki AM, Itani KM, et al. Validity of selected patient safety indicators: opportunities and concerns. J Am Coll Surg. 2011;212(6):924–934.CrossRefPubMed
20.
Ramanathan R, Leavell P, Wolfe LG, Duane TM. Agency for healthcare research and quality patient safety indicators and mortality in surgical patients. Am Surg. 2014;80(8):801–804.PubMed
21.
Ramanathan R, Leavell P, Mays C, Duane TM. Impact of sepsis on surgical outcomes. Surg Infect (Larchmt). 2015;16(4):405–409.CrossRefPubMed
22.
Sellers MM, Merkow RP, Halverson A, et al. Validation of new readmission data in the American College of Surgeons National Surgical Quality Improvement Program. J Am Coll Surg. 2013;216(3):420–427.CrossRefPubMed
23.
Fong ZV, Ferrone CR, Thayer SP, et al. Understanding hospital readmissions after pancreaticoduodenectomy: can we prevent them?: a 10-year contemporary experience with 1,173 patients at the massachusetts general hospital. J Gastrointest Surg. 2014;18(1):137–44; discussion 144-5.CrossRefPubMed
24.
Kastenberg ZJ, Morton JM, Visser BC, Norton JA, Poultsides GA. Hospital readmission after a pancreaticoduodenectomy: an emerging quality metric? HPB (Oxford). 2013;15(2):142–148.CrossRef
25.
Kent TS, Sachs TE, Callery MP, Vollmer CM,Jr. Readmission after major pancreatic resection: a necessary evil? J Am Coll Surg. 2011;213(4):515–523.CrossRefPubMed
26.
Yermilov I, Bentrem D, Sekeris E, et al. Readmissions following pancreaticoduodenectomy for pancreas cancer: a population-based appraisal. Ann Surg Oncol. 2009;16(3):554–561.CrossRefPubMed
27.
Reddy DM, Townsend CM,Jr, Kuo YF, Freeman JL, Goodwin JS, Riall TS. Readmission after pancreatectomy for pancreatic cancer in Medicare patients. J Gastrointest Surg. 2009;13(11):1963–74; discussion 1974-5.CrossRefPubMedPubMedCentral
28.
Emick DM, Riall TS, Cameron JL, et al. Hospital readmission after pancreaticoduodenectomy. J Gastrointest Surg. 2006;10(9):1243–52; discussion 1252-3.CrossRefPubMed
29.
Epelboym I, Gawlas I, Lee JA, Schrope B, Chabot JA, Allendorf JD. Limitations of ACS-NSQIP in reporting complications for patients undergoing pancreatectomy: underscoring the need for a pancreatectomy-specific module. World J Surg. 2014;38(6):1461–1467.CrossRefPubMed
30.
Grewal SS, McClaine RJ, Schmulewitz N, et al. Factors associated with recidivism following pancreaticoduodenectomy. HPB (Oxford). 2011;13(12):869–875.CrossRefPubMedPubMedCentral
31.
Cocoros NM, Klompas M. Ventilator-associated events and their prevention. Antimicrob Resist Infect Control. 2016;14(5):43.
32.
Passaro L, Harbarth S, Landelle C. Prevention of hospital-acquired pneumonia in non-ventilated adult patients: a narrative review. BMJ Open. 2014;25(4):e006065.
33.
Herzer KR, Niessen L, Constenla DO, Ward WJ Jr, Pronovost PJ. Cost-effectiveness of a quality improvement programme to reduce central line-associated bloodstream infections in intensive care units in the USA. Pancreatology. 2017;17(5):805–813.CrossRef
34.
Alexander JW, Solomkin JS, Edwards MJ. Updated recommendations for control of surgical site infections. Ann Surg. 2011;253(6):1082–1093.CrossRefPubMed
35.
Holubar SD, Hedrick T, Gupta R, et al. American society for enhanced recovery (ASER) and perioperative quality initiative (POQI) joint consensus statement on prevention of postoperative infection within an enhanced recovery pathway for elective colorectal surgery. Perioper Med (Lond). 2017;6:4-017-0059-2. eCollection 2017.
36.
Causey MW, Maykel JA, Hatch Q, Miller S, Steele SR. Identifying risk factors for renal failure and myocardial infarction following colorectal surgery. J Surg Res. 2011;170(1):32–37.CrossRefPubMed
37.
Ramanathan R, Gu Z, Limkemann AJ, et al. Association between interruptions in chemical prophylaxis and VTE formation. Am Surg. 2015;81(7):732–737.PubMed
38.
Ramanathan R, Lee N, Duane TM, et al. Correlation of venous thromboembolism prophylaxis and electronic medical record alerts with incidence among surgical patients. Surgery. 2016;160(5):1202–1210.CrossRefPubMed
39.
Callery MP, Pratt WB, Kent TS, Chaikof EL, Vollmer CM,Jr. A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy. J Am Coll Surg. 2013;216(1):1–14.CrossRefPubMed
40.
Pratt WB, Callery MP, Vollmer CM, Jr. Risk prediction for development of pancreatic fistula using the ISGPF classification scheme. World J Surg. 2008;32(3):419–428.CrossRefPubMed
41.
Ricci C, Casadei R, Taffurelli G, et al. Is pancreaticogastrostomy safer than pancreaticojejunostomy after pancreaticoduodenectomy? A meta-regression analysis of randomized clinical trials. Biomed Res Int. 2017;(2017):1367238.
42.
Hong S, Wang H, Yang S, Yang K. External stent versus no stent for pancreaticojejunostomy: a meta-analysis of randomized controlled trials. J Gastrointest Surg. 2009;13(7):1184–6.CrossRef
43.
Zhao Y, Zhang J, Lan Z, et al. Are internal or external pancreatic duct stents the preferred choice for patients undergoing pancreaticoduodenectomy? a meta-analysis. J Gastrointest Surg. 2013;17(8):1516–25.CrossRef
44.
Schulick RD, Yoshimura K. Stents, glue, etc.: is anything proven to help prevent pancreatic leaks/fistulae? Ann Surg. 2016;264(3):528–37.CrossRef
45.
Witzigmann H, Diener MK, Kienkötter S, et al. No need for routine drainage after pancreatic head resection: the dual-center, randomized, controlled PANDRA trial (ISRCTN04937707). J Surg Res. 2016;202(2):380–8.CrossRef
46.
Hanna MM, Gadde R, Allen CJ, et al. Delayed gastric emptying after pancreaticoduodenectomy. World J Surg. 2014;38(11):2960–6.CrossRef
47.
Braga M, Pecorelli N, Ariotti R, et al. Enhanced recovery after surgery pathway in patients undergoing pancreaticoduodenectomy. Br J Surg. 2015;102(13):1676–83.CrossRef
48.
Joliat GR, Labgaa I, Petermann D, et al. Cost-benefit analysis of an enhanced recovery protocol for pancreaticoduodenectomy. Infect Dis Clin North Am. 2016;30(4):887–908.CrossRef
49.
McMillan RR, Berger A, Sima CS, et al. Thirty-day mortality underestimates the risk of early death after major resections for thoracic malignancies. Ann Thorac Surg. 2014;98(5):1769–74; discussion 1774-5.CrossRefPubMedPubMedCentral
Metadata
Title
Predictors of Short-Term Readmission After Pancreaticoduodenectomy
Authors
Rajesh Ramanathan
Travis Mason
Luke G. Wolfe
Brian J. Kaplan
Publication date
01-06-2018
Publisher
Springer US
Published in
Journal of Gastrointestinal Surgery / Issue 6/2018
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-018-3700-6

Other articles of this Issue 6/2018

Journal of Gastrointestinal Surgery 6/2018 Go to the issue

Original Article

Enhanced Recovery via Peripheral Nerve Block for Open Hepatectomy

GI Image

Inflammatory Myofibroblastic Tumor of the Liver: Challenges in the Preoperative Diagnosis and Treatment

Letter to the Editor

Postoperative Pain and Opioid Consumption in the Acute Postoperative Period after Laparoscopic Gastrectomy

Original Article

Do I Need to Operate on That in the Middle of the Night? Development of a Nomogram for the Diagnosis of Severe Acute Cholecystitis

Original Article

Impact of Preoperative Opioid Use After Emergency General Surgery

Original Article

Neoadjuvant Radiation Is Associated with Fistula Formation Following Pancreaticoduodenectomy